4CPS-037 Analysis of usage profile, effectiveness and safety of alirocumab in a tertiary hospital

BACKGROUND: Hypercholesterolaemia is a common and growing health problem, above all in developed countries, which can cause serious consequencies in patients who suffer from it. Alirocumab is a monoclonal antibody that blocks a protein called PCSK9 and prevents LDL cholesterol receptors being absorb...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur J Hosp Pharm
Prif Awduron: Garcia, C Mondelo, Bargiela, N Fernández, Olivera, C Fernández, Filgueiras, J Balea, Arufe, V Giménez, Herranz, MI Martín
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Group 2018
Pynciau:
Section 4: Clinical pharmacy services
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535505/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.128
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg